Edition:
United States

Aileron Therapeutics Inc (ALRN.OQ)

ALRN.OQ on NASDAQ Stock Exchange Global Market

8.40USD
23 Feb 2018
Change (% chg)

$0.41 (+5.13%)
Prev Close
$7.99
Open
$8.03
Day's High
$8.57
Day's Low
$8.03
Volume
6,270
Avg. Vol
8,426
52-wk High
$15.34
52-wk Low
$7.60

Chart for

About

Aileron Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and... (more)

Overall

Beta: --
Market Cap(Mil.): $123.60
Shares Outstanding(Mil.): 14.71
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 195.87 16.59
EPS (TTM): -- -- --
ROI: -- -0.71 35.07
ROE: -- -3.37 17.79

BRIEF-Apple Tree Partners Sells 150,000 Shares Of Aileron Therapeutics Inc's Common Stock On Jan 9

* APPLE TREE PARTNERS II LP REPORTS SALE OF 150,000 SHARES OF AILERON THERAPEUTICS INC'S COMMON STOCK ON JAN 9 AT $9.80 PER SHARE - SEC FILING Source text: (http://bit.ly/2DiFGmF) Further company coverage:

Jan 11 2018

BRIEF-Aileron Therapeutics posts Q3 loss of $0.45 per share

* Aileron therapeutics reports third quarter 2017 financial results

Nov 09 2017

Earnings vs. Estimates